Eflornithine

Results: 13



#Item
1

PDF Document

Add to Reading List

Source URL: www.swisstph.ch

Language: English - Date: 2013-09-12 05:44:15
2Biomarkcrs in Cancer ChemepreveritFon Miller A.B., Bar1ncl H., Baffefla, P., Dragated, L. and Vo nia, H. edc ARC Scientific Publications No. 154 International Agency for Research on Cancer, Lyon, 2001 ornithine and Bowm

Biomarkcrs in Cancer ChemepreveritFon Miller A.B., Bar1ncl H., Baffefla, P., Dragated, L. and Vo nia, H. edc ARC Scientific Publications No. 154 International Agency for Research on Cancer, Lyon, 2001 ornithine and Bowm

Add to Reading List

Source URL: www.iarc.fr

Language: English - Date: 2015-02-25 08:41:08
3Access to Drugs for African Trypanosomiasis (sleeping sickness) Due to difficulties by some GeoSentinel sites in obtaining drugs for patients acutely ill with sleeping sickness, GeoSentinel has worked with ISTM WHO Liais

Access to Drugs for African Trypanosomiasis (sleeping sickness) Due to difficulties by some GeoSentinel sites in obtaining drugs for patients acutely ill with sleeping sickness, GeoSentinel has worked with ISTM WHO Liais

Add to Reading List

Source URL: 111412f.membershipsoftware.org

Language: English
4In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness Caecilia Schmid1,2, Andrea Kuemmerle1,2¤, Johannes Blum1,2, Salah Ghabri3, Victor Kande4

In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness Caecilia Schmid1,2, Andrea Kuemmerle1,2¤, Johannes Blum1,2, Salah Ghabri3, Victor Kande4

Add to Reading List

Source URL: www.dndi.org

Language: English - Date: 2012-11-30 04:05:18
5 NECT IN BRIEF • AN IMPROVED TREATMENT OPTION The Nifurtimox-Eflornithine Combination Therapy (NECT) is a new, improved treatment option for stage 2 (advanced stage) Human African trypanosomiasis (HAT) also known as sl

NECT IN BRIEF • AN IMPROVED TREATMENT OPTION The Nifurtimox-Eflornithine Combination Therapy (NECT) is a new, improved treatment option for stage 2 (advanced stage) Human African trypanosomiasis (HAT) also known as sl

Add to Reading List

Source URL: www.dndi.org

Language: English - Date: 2013-06-25 04:11:53
6MAJOR ARTICLE Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Médecins Sans Frontières Experience in the Democratic Republic of the

MAJOR ARTICLE Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Médecins Sans Frontières Experience in the Democratic Republic of the

Add to Reading List

Source URL: www.dndi.org

Language: English - Date: 2014-06-13 11:32:12
76ème Journée et Prix de la Recherche Clinique Présentations orales _________________________________________________________________________________ NIFURTIMOX-EFLORNITHINE COMBINATION THERAPY (NECT) FOR SECOND-STAGE

6ème Journée et Prix de la Recherche Clinique Présentations orales _________________________________________________________________________________ NIFURTIMOX-EFLORNITHINE COMBINATION THERAPY (NECT) FOR SECOND-STAGE

Add to Reading List

Source URL: www.hug-ge.ch

Language: English - Date: 2015-01-06 11:28:02
8Evaluation and Treatment of Hirsutism in Premenopausal Women A Patient’s Guide Hirsutism refers to excessive growth of terminal hair (the kind of hair that grows on your head) in areas where women typically grow fine (

Evaluation and Treatment of Hirsutism in Premenopausal Women A Patient’s Guide Hirsutism refers to excessive growth of terminal hair (the kind of hair that grows on your head) in areas where women typically grow fine (

Add to Reading List

Source URL: www.hormone.org

Language: English - Date: 2014-02-04 16:55:55
9VANIQA® (eflornithine hydrochloride) cream, 13.9% For topical dermatological use only. Not for ophthalmic, oral, or intravaginal use. DESCRIPTION VANIQA® is a cream containing 13.9% (139 mg/g) of anhydrous eflornithine

VANIQA® (eflornithine hydrochloride) cream, 13.9% For topical dermatological use only. Not for ophthalmic, oral, or intravaginal use. DESCRIPTION VANIQA® is a cream containing 13.9% (139 mg/g) of anhydrous eflornithine

Add to Reading List

Source URL: www.allergan.com

Language: English - Date: 2013-09-10 17:06:46
10Proposed changes for Antitrypanosomal medicines: treatments for Human African Trypanosomiasis (HAT)

Proposed changes for Antitrypanosomal medicines: treatments for Human African Trypanosomiasis (HAT)

Add to Reading List

Source URL: archives.who.int

Language: English - Date: 2008-07-08 09:43:36